MONROVIA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced today that it will present at the at the upcoming Fourth Annual Noble Financial Equity Conference which will be held Monday, August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, Nevada. Barry G. Caldwell, President and Chief Executive Officer will discuss the Company's business strategy and historical financial performance at 11:00 a.m. Pacific Time on Monday, August 18th.
A live audio webcast of STAAR Surgical's presentation may be accessed through the Company's website at http://www.staar.com. The presentation will feature high-definition, streaming video and PowerPoint slides. It is recommended that interested parties register 15 minutes prior to the start of the presentation to ensure timely access. An archived replay of the presentation will be available after the live presentation, and can also be accessed at http://www.staar.com.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and
marketing of minimally invasive ophthalmic products employing proprietary
technologies. STAAR's products are used by ophthalmic surgeons and include
the Visian ICL, a tiny, flexible lens implanted to correct refractive
errors, as well as innovative products designed to improve patient outcomes
for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL
is approved by the FDA for use in treating myopia, has received CE Marking
and is sold in more than 40 countries. Collamer(R) is the brand name for
STAAR's proprietary collagen copolymer lens material. More information is
available at http://www.staar.com.
CONTACT: Investors Media
EVC Group EVC Group
Dahlia Bailey, 415-896-5862 Steve DiMattia 646-201-5445
|SOURCE STAAR Surgical Company|
Copyright©2008 PR Newswire.
All rights reserved